ライフサイエンスコーパス: gastrointestinal hemorrhage

1 in cohort 2 (three neutropenia and two upper gastrointestinal hemorrhage).

2 es in patients with severe nonvariceal upper gastrointestinal hemorrhage.

3 in England following hospital admission for gastrointestinal hemorrhage.

4 esophageal varices are a rare cause of upper gastrointestinal hemorrhage.

5 estive heart failure, pneumonia, sepsis, and gastrointestinal hemorrhage.

6 py improves the outcome of nonvariceal upper gastrointestinal hemorrhage.

7 risk of bleeding, including intracranial and gastrointestinal hemorrhage.

8 One patient suffered a postoperative gastrointestinal hemorrhage.

9 be associated with an increased incidence of gastrointestinal hemorrhage.

10 neumonia, sepsis, electrolyte disorders, and gastrointestinal hemorrhage.

11 tigraphy in the localization of active lower gastrointestinal hemorrhage.

12 certainty) but did not increase frequency of gastrointestinal hemorrhage.

13 s of all patients who underwent VA for lower gastrointestinal hemorrhage.

14 r aleglitazar vs 2.8% for placebo, P = .14), gastrointestinal hemorrhages (2.4% for aleglitazar vs 1.

15 tachycardia (3%), thoracic pain (3%), upper gastrointestinal hemorrhage (3%), and vomiting (3%).

16 y all-cause mortality rates among those with gastrointestinal hemorrhage (5.0% vs 5.8%; adjusted mort

17 n percent of patients had moderate or severe gastrointestinal hemorrhage, 6.4% had moderate or severe

18 ter kidney transplantation, 10 patients with gastrointestinal hemorrhage, 8 patients with head-and-ne

19 reatment and outcomes of patients with upper gastrointestinal hemorrhage admitted to major teaching h

20 the developing world, are a leading cause of gastrointestinal hemorrhage and iron deficiency anemia.

21 hrough which these parasitic nematodes cause gastrointestinal hemorrhage and iron deficiency anemia.

22 atient in the dexamethasone group had occult gastrointestinal hemorrhage and one patient in each grou

23 In the ablation group, one patient had upper gastrointestinal hemorrhage, and five patients (6.0%) ha

24 ncidence of ventilator-associated pneumonia, gastrointestinal hemorrhage, and in-hospital mortality r

25 a) ventilator-associated pneumonia; b) upper gastrointestinal hemorrhage; c) bacteremia; d) barotraum

26 Massive upper gastrointestinal hemorrhage can be the dominant symptom

27 s positive localization of the site of lower gastrointestinal hemorrhage compared with VA alone.

28 rhage, and death and increased risk of major gastrointestinal hemorrhage compared with warfarin in el

29 One patient had a serious upper gastrointestinal hemorrhage considered unrelated to test

30 ollowing both nonvariceal and variceal upper gastrointestinal hemorrhage decreased from 1999 to 2007,

31 He died after severe gastrointestinal hemorrhage developed.

32 complications included toxemia, lupus flare, gastrointestinal hemorrhage due to Mallory-Weiss tear, p

33 nt visceral angiography (VA) for acute lower gastrointestinal hemorrhage from January 1, 2005, to Dec

34 ntrolled trial of patients with severe upper gastrointestinal hemorrhage from ulcers or other lesions

35 National Health Service hospital, for upper gastrointestinal hemorrhage, from 1999 to 2007 (n=516,15

36 higher bleeding incidence in GVHD was due to gastrointestinal hemorrhage, hemorrhagic cystitis, and p

37 ion, congestive heart failure, acute stroke, gastrointestinal hemorrhage, hip fracture, and pneumonia

38 ver diseases; alcohol-related liver disease; gastrointestinal hemorrhage; human immunodeficiency infe

39 hovah's Witness presented with massive upper gastrointestinal hemorrhage; initial hemoglobin was 3.5

40 It is unclear whether mortality from upper gastrointestinal hemorrhage is changing: any differences

41 Hospital mortality, intracranial and gastrointestinal hemorrhage, major transfusion.

42 ce of diagnostic imaging when managing lower gastrointestinal hemorrhage may reduce subsequent morbid

43 ration (n = 6), postoperative ileus (n = 3), gastrointestinal hemorrhage (n = 2), delayed splenic rup

44 ompared mortality for patients admitted with gastrointestinal hemorrhage (n = 39,409) or acute myocar

45 4; 10%) elevated transaminases (n = 4; 10%), gastrointestinal hemorrhage (n = 5; 12.5%), wound infect

46 atio, 0.35 [CI, 0.31 to 0.40]), and previous gastrointestinal hemorrhage (odds ratio, 0.47 [CI, 0.40

47 CI 63-86%), cirrhosis (PPV 60%; 47-73%), and gastrointestinal hemorrhage (PPV 62%; 51-73%) had improv

48 In patients with upper gastrointestinal hemorrhage, teaching hospitals do not a

49 bitors (coxibs) were developed to cause less gastrointestinal hemorrhage than nonselective nonsteroid

50 of selected patients with nonvariceal upper gastrointestinal hemorrhage (UGIH) has been proposed as

51 Triage of patients with acute upper gastrointestinal hemorrhage (UGIH) has traditionally req

52 The rate of minor gastrointestinal hemorrhage was increased.

53 mally incorporated CTA to manage acute lower gastrointestinal hemorrhage was launched after multidisc

54 Minor, but not major, gastrointestinal hemorrhage was more common in the early

55 dy of 124 patients admitted with acute upper gastrointestinal hemorrhage was performed.

56 th severe, life-threatening anemia caused by gastrointestinal hemorrhage who refused all blood produc